A detailed history of Wolverine Trading, LLC transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 29,344 shares of CRDF stock, worth $125,005. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,344
Previous 14,992 95.73%
Holding current value
$125,005
Previous $33,000 136.36%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.05 - $2.77 $29,421 - $39,755
14,352 Added 95.73%
29,344 $78,000
Q2 2024

Aug 14, 2024

SELL
$2.22 - $5.89 $3,274 - $8,687
-1,475 Reduced 8.96%
14,992 $33,000
Q1 2024

May 15, 2024

BUY
$1.46 - $5.91 $24,041 - $97,319
16,467 New
16,467 $87,000

Others Institutions Holding CRDF

About Cardiff Oncology, Inc.


  • Ticker CRDF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,334,900
  • Market Cap $185M
  • Description
  • Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...
More about CRDF
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.